McKesson Corporation

NYSE:MCK

Medical - Distribution

Healthcare
$1,084.43 -3.71%

-$28.96 today

Market cap
$125.21B
Beta
0.32
P/E (TTM)
19.3
EPS (TTM)
$39.00
Dividend yield
0.44%
52W Low $637.00High $999.00

Volume 0.67M

Average 1.03M

MCK EBITDA Margin

EBITDA as a percentage of revenue.

McKesson CorporationNYSE: MCK

EBITDA Margin · Q1 FY2027 · quarter ended Jun 2026

EBITDA Margin holds steady near 1.5%

EBITDA Margin was 1.5% in Q1 FY2027, up 0.2 pp from a year earlier. On a trailing-twelve-month basis it was 1.8%, up 0.4 pp year over year. Over 3 fiscal years it narrowed by 0.2 pp.

Context

  • EBITDA Margin widened in 1 of the last 3 fiscal years.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 12 analysts of 2.0% for the fiscal year ending Mar 2027, up from 1.8% in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
1.5%-0.8 pp QoQ
Last fiscal yearMar 2026
1.8%+0.3 pp YoY
LTMJun 2026
1.8%+0.4 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+0.2 pp+0.2 pp+0.0 pp
1 year+0.3 pp+0.2 pp-0.1 pp
3 years-0.2 pp+0.5 pp+0.7 pp
5 years+0.9 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2026
1.8%
Year-over-year change
+0.3pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How MCK compares with its peers on the latest reported figures

  • MCK's LTM Jun 2026 EBITDA Margin of 1.8% is the 2nd highest of the 4 companies compared; the peer median is 1.5%.
  • Its year-over-year change of +0.4 pp is the 2nd highest of 4, against a peer median of +0.3 pp.
  • Over three fiscal years its change of -0.2 pp compares with a peer median of +0.7 pp.
MCK Competitors Peer median
EBITDA Margin for MCK and competitors
Company Period LTM level YoY 3-year change
ACHAccendra Health, Inc.LTM Mar 202612.7% +12.2 pp+9.5 pp
MCKMcKesson CorporationLTM Jun 20261.8% +0.4 pp-0.2 pp
CORCencora, Inc.LTM Jun 20261.5% +0.3 pp-0.1 pp
CAHCardinal Health, Inc.LTM Sep 20261.4% -0.0 pp+0.7 pp
Peer median (excluding MCK) 1.5%+0.3 pp+0.7 pp

Competitors are the stored peer set for MCK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue263.97B276.71B308.95B359.05B403.43B
Cost of Revenue251.32B264.84B296.75B346.57B388.88B
Gross Profit12.65B11.87B12.2B12.49B14.55B
Gross Margin4.8%4.3%3.9%3.5%3.6%
Research & Development70M89M77M91M103M
Selling, General & Admin9.86B7.33B8.2B8.02B(8.1B)
Operating Expenses9.93B7.42B8.28B8.11B8.1B
Depreciation & Amortization760M608M635M636M729M
EBITDA2.87B5.49B4.67B5.25B7.18B
EBITDA Margin1.1%2.0%1.5%1.5%1.8%
Operating Income2.72B4.45B3.93B4.37B6.45B
Operating Margin1.0%1.6%1.3%1.2%1.6%
Interest Income10M107M118M173M179M
Interest Expense178M248M243M256M247M
Other Income / Expenses(795M)177M(138M)(13M)(253M)
Income Before Tax1.93B4.63B3.79B4.36B6.2B
Pre-Tax Margin0.7%1.7%1.2%1.2%1.5%
Income Tax Expense636M905M629M878M1.1B
Net Income1.11B3.56B3B3.3B4.76B
Net Margin0.4%1.3%1.0%0.9%1.2%
EPS (Basic)7.3125.2322.5425.8638.55
EPS (Diluted)7.2325.0422.3925.7238.38
Weighted Avg Shares152.3M141.1M133.2M127.4M123.6M
Weighted Avg Shares (Diluted)154.1M142.2M134.1M128.1M124.1M

McKesson Corporation

NYSE:MCK

Intrinsic Alpha fair value

Locked

Current Price

$1,084.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.